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number of breath-holds required were observed during the 
courses of treatment. 
 
 
 
Conclusion: Breath-hold capabilities are highly individual and 
generally not observed to be changing during the course of 
treatment. The ratio between DIBH and FB total lung volume 
was observed to be stable during the course of treatment, 
while systematic decreases in GTV were observed both in 
DIBH and FB. DIBH radiotherapy of locally advanced NSCLC 
patients is considered to be feasible with geometrical 
reproducibility. 
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Purpose or Objective: The aim of radiotherapy is accurate 
delivery of dose to target volumes within a patient, while 
minimizing dose to the surrounding healthy tissue. 
Respiratory motion is still a significant problem in many 
radiotherapy treatments. Recent developments in the 
treatment of breast cancer have focused on “gating” the 
delivery of the treatment beams. With this technique, the 
effect of patient motion during treatment is reduced and the 
separation between the target volume and organs at risk 
(OAR) increased. Rapidly switching the treatment beam on or 
off, depending on the patient breathing cycle is the basic 
principle of gating. It is therefore important that the 
characteristics of gated treatments such as latency are 
known. 
 
Material and Methods: For this study, an in-house built 
electrical PIN diode circuit was designed to function as a tool 
for quality assurance (QA). Beam latency timing properties 
were measured on a TrueBeam™ (Varian, Palo Alto) linear 
accelerator and its internal gating system. Pulses of 
radiation, triggered within a predefined gating window, were 
measured with the PIN diode and the results compared to 
measurements of current through the linac target. A phantom 
consisting of the electrical circuit coupled to a moving stage 
was used to simulate a binary pattern to produce fast beam 
triggering. Processing of the beam pulses and calculation of 
the latency timings was performed by an Atmega328P 
microcontroller (MCU). All measurements were performed 
with photon energies 6MV and 10MV and a dose rate of 
600MU/min (equivalent to a reference dose in water of 6 
Gy/min). For every measurement, a total of 50 data points 
were collected and the results compared by calculating the 
arithmetic mean value and the standard deviation.  
 
 
Results: The results of the beam latency measurements are 
shown in the table below. 
 
Beam on 
latency (ms)  
Beam off 
latency (ms)  
Energy Target I PIN diode Target I PIN diode 
6 MV 2.13 ±1.15 2.11 ±1.05 57.33 ±10.01 57.69 ±9.59 
10 MV 2.15 ±1.06 2.12 ±1.09 56.01 ±10.10 57.73 ±10.06 
 
Conclusion: Measuring beam gating latencies of a linear 
accelerator via beam pulse analyses with the help of a PIN 
diode and the in-house built electrical circuit is a useful 
method in good agreement with measurements from the 
accelerator target current signal. The PIN diode circuit 
provided a good response when using different beam energies 
and can be a useful tool to perform QA on different types of 
linear accelerators and gating systems. This could potentially 
lead to improvements in the gated radiotherapy treatments. 
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Purpose or Objective: Respiration motion during 
radiotherapy of breast cancer patients will perturb the 
delivered dose. The accuracy of the delivered dose can be 
measured by in vivo EPID dosimetry. The respiration motion 
can be reduced by use of the Active Breathing Coordinator 
(ABC) produced by Elekta. This study investigates whether a 
difference in EPID measured acceptance pass rate is 
associated to the use of ABC and whether the residual 
breathing variation while using the ABC system is associated 
to the measured pass rate. 
 
Material and Methods: 15 ABC and 10 non-ABC breast cancer 
patients were monitored by EPID dosimetry for up to five 
fractions during the treatment. In total 185 and 82 tangential 
fields were available for analysis for ABC and non-ABC 
groups, respectively. The in vivo EPID dosimetry system 
(Wendling et al. Med Phys 2006) back projects the dose to a 
plane parallel to the EPID panel that includes the prescription 
point. The dose is compared to the planned distribution using 
a gamma analysis (3%, 3mm) and defines the pass rate as the 
fraction of gamma values less than one. Since pass rates are 
not normally distributed comparison between the ABC and 
non-ABC group was performed by a Mann-Whitney U test. The 
ABC system measured the amount of actual inhaled air at 
each treatment session and during the treatment planning 
CT. At breath-holds during treatment, deviation in inhaled air 
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(Vol_dif = Vol_treatment – Vol_CT) could potentially 
influence the pass rate negatively. Association between 
Vol_dif and gamma pass rates was analysed by linear 
regression between the gamma pass rates and Vol_dif 
squared. In order to adjust at least partially for the residual 
setup uncertainty, the regression was performed including 
the fraction number as predictor variable since fields within 
a fraction are assumed to have the same setup uncertainty. 
 
Results: Difference between pass rates for the ABC and non-
ABC group was highly statistically significant (p<0.001), with 
median pass rates of 84.7% and 76.1%, respectively (see 
figure). However, within the ABC group no significant 
association was observed between pass rates and deviation of 
inhaled air relative to the reference from the planning CT. 
EPID images were used to evaluate patient positioning prior 
to treatment and only accepted if deviations were less than 5 
mm. Thus, it seems likely that the residual positioning 
uncertainty is the dominant uncertainty relative to the 
uncertainty in breath-hold volume when using ABC. 
 
 
 
Conclusion: Breast cancer patients treated with the use of 
ABC showed an improved EPID dosimetry pass rate, reflecting 
an improved accuracy of dose delivery. However, a potential 
patient selection bias exists since no randomization between 
groups was performed. No significant association was 
observed between Vol_dif and pass rate within the ABC 
group. The ABC system therefore performs as intended and 
errors in breath-hold volumes are not of concern given the 
residual setup uncertainties. 
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Purpose or Objective: Intra-fraction motion of the prostate 
during irradiation requires large PTV margins. The recently 
released imaging application Triggered Imaging (TI, Varian 
Medical Systems, Palo Alto CA) allows to generate 2D kV 
images at predefined intervals during irradiation. The 
application can automatically detect implanted fiducial 
markers and initiate beam interrupt. Our previous work 
shows that re-setup was justified for almost half of the beam 
interrupts based on a 6mm tolerance. This study describes 
how applying TI and re-setup in the clinical workflow resulted 
in the reduction of the PTV margin. 
 
Material and Methods: A total of 96 prostate cancer patients 
with implanted gold seeds were treated on the Truebeam 
with two RapidArc beams (Software version 2.0, Varian 
Medical Systems, Palo Alto, CA). For patient setup, the gold 
seeds are lined up using two orthogonal 2D kV images. After 
the setup procedure, TI is applied during both beams at an 
interval of 3 seconds, resulting in 41 images per fraction.In 
the plannings CT, the center of gravity of each seed is 
defined as a Marker. During treatment, each seed is 
automatically detected on each acquired Triggered Image 
and its center of gravity is marked with a cross. A circular 
overlay centered at the Marker position is projected on each 
Triggered Image. The radius of this circle indicates the 
maximum allowed seed deviation and is referred to as the TI 
limit. A color coding is used to indicate whether the seed is 
in or outside the TI limit (Fig 1).If one or more gold seeds 
exceed the limit for more than 6 seconds the beam is 
manually paused, while TI continues at the same gantry 
angle. If the deviation persists for another 6 seconds, the 
beam is interrupted and re-setup is performed using two 
orthogonal 2D kV images.For a first group of patients (n=27) 
TI was used, with the TI limit set to 6mm which corresponds 
to the PTV margin. For a second group of patients (n=32) the 
TI limit is set to 5mm, with an unchanged PTV margin of 
6mm. For a third group (n=37) the PTV margin was reduced 
to 5mm, along with a TI limit of 5mm.  
 
 
 
Results: For the total of 1434 fractions, 134 fractions showed 
excessive intra-fraction motion of one or more gold seeds 
leading to 173 beam interruptions and re-setups. Translations 
applied in re-setup were on average: 3mm, 3mm and 1mm in 
ventrodorsal, longitudinal and lateral directions, 
respectively. Overall, the average shift magnitude was 5mm 
(SD: 2.2mm) with a maximum of 13mm. Shift magnitudes 
exceeding the PTV margin were considered justified. Table 1 
shows that a TI limit that equals the PTV margin leads to 
about 45% of justified interruptions.  
 
 
 
Conclusion: Triggered Imaging in combination with auto-
detection provides a powerful tool to monitor tumor motion 
during treatment for patients with implanted fiducial 
markers. We have developed a strategy for intra-fraction re-
setup allowing for PTV margin reduction with limited increase 
in workload. 
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Purpose or Objective: In SBRT it is typical to prescribe a 
lower dose to an isodose-line encompassing the PTV rim 
rather than prescribing a uniform PTV dose. This strategy 
may allow for a higher central tumor dose than achievable by 
conventional homogenous dose prescription while maintaining 
an acceptable risk of normal tissue toxicity. However, the 
tumor dose may deteriorate because of intra-fraction motion. 
The aim of this study was to determine an optimal dose 
prescription strategy when explicitly considering the effects 
of intra-treatment motion in liver SBRT. 
 
Material and Methods: Six patients received liver SBRT in 3 
fractions. The PTV was generated from the CTV by adding 
margins of 5mm (LR,AP) and 10mm (CC). The 3-D motion of 
an implanted gold marker was monitored throughout each 
fraction by fluoroscopic kV and MV imaging. Later, five VMAT 
treatment plans with different PTV dose coverage were 
